Critical role of endoplasmic reticulum aminopeptidase 1 in determining the length and sequence of peptides bound and presented by HLA-B27

Arthritis and Rheumatology

Volumn 66, Issue 2, 2014, Pages 284-294

  Chen, Liye ^a   Fischer, Roman ^a   Peng, Yanchun ^a   Reeves, Emma ^b   McHugh, Kirsty ^a   Ternette, Nicola ^a   Hanke, Tomas ^a   Dong, Tao ^a   Elliott, Tim ^b   Shastri, Nilabh ^c   Kollnberger, Simon ^a   James, Edward ^b   Kessler, Benedikt ^a   Bowness, Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; ARGININE; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; HLA B27 ANTIGEN; KK10 PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; FIBROBLAST; GENE MUTATION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; ISOTOPE LABELING; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE LENGTH; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; TANDEM MASS SPECTROMETRY; VACCINIA VIRUS; VIRUS RECOMBINANT; WILD TYPE;

AMINOPEPTIDASES; ANIMALS; B-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPITOPES; GENE SILENCING; HELA CELLS; HLA-B27 ANTIGEN; HUMANS; MICE, KNOCKOUT; MUTATION; PEPTIDES; RNA, SMALL INTERFERING; SPONDYLITIS, ANKYLOSING; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84896269583     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38249     Document Type: Article

References (43)

1. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007;39: 1329-37.
2. Davidson SI, Wu X, Liu Y, Wei M, Danoy PA, Thomas G, et al. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum 2009;60: 3263-8.
3. Harvey D, Pointon JJ, Evans DM, Karaderi T, Farrar C, Appleton LH, et al. Investigating the genetic association between ERAP1 and ankylosing spondylitis. Hum Mol Genet 2009;18: 4204-12.
4. Maksymowych WP, Inman RD, Gladman DD, Reeve JP, Pope A, Rahman P. Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis Rheum 2009;60: 1317-23.
5. Pimentel-Santos FM, Ligeiro D, Matos M, Mourao AF, Sousa E, Pinto P, et al. Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clin Exp Rheumatol 2009;27: 800-6.
6. Bang SY, Kim TH, Lee B, Kwon E, Choi SH, Lee KS, et al. Genetic studies of ankylosing spondylitis in Koreans confirm associations with ERAP1 and 2p15 reported in white patients. J Rheumatol 2011;38: 322-4.
7. Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011;43: 761-7.
8. York IA, Chang SC, Saric T, Keys JA, Favreau JM, Goldberg AL, et al. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol 2002;3: 1177-84.
9. Saric T, Chang SC, Hattori A, York IA, Markant S, Rock KL, et al. An IFN - induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol 2002;3: 1169-76.
10. Serwold T, Gonzalez F, Kim J, Jacob R, Shastri N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 2002;419: 480-3.
11. Strange A, Capon F, Spencer CC, Knight J, Weale ME, Allen MH, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010;42: 985-90.
12. Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, et al. Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet 2013;45: 202-7.
13. Blanchard N, Kanaseki T, Escobar H, Delebecque F, Nagarajan NA, Reyes-Vargas E, et al. Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. J Immunol 2010;184: 3033-42.
14. McHugh K, Bowness P. The link between HLA-B27 and SpA-new ideas on an old problem. Rheumatology (Oxford) 2012;51: 1529-39.
15. Bird LA, Peh CA, Kollnberger S, Elliott T, McMichael AJ, Bowness P. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur J Immunol 2003;33: 748-59.
16. Ellis SA, Taylor C, McMichael A. Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum Immunol 1982;5: 49-59.
17. Tan CT, Croft NP, Dudek NL, Williamson NA, Purcell AW. Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring. Proteomics 2011;11: 2336-40.
18. Fischer R, Trudgian DC, Wright C, Thomas G, Bradbury LA, Brown MA, et al. Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis. Mol Cell Proteomics 2012;11:M111.013904.
19. Chambers MC, Maclean B, Burke R, Amodei D, Ruderman DL, Neumann S, et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol 2012;30: 918-20.
20. Ramos M, Paradela A, Vazquez M, Marina A, Vazquez J, Lopez de Castro JA. Differential association of HLA-B*2705 and B*2709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability. J Biol Chem 2002;277: 28749-56.
21. Nixon DF, Townsend AR, Elvin JG, Rizza CR, Gallwey J, McMichael AJ. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 1988;336: 484-7.
22. Giles J, Shaw J, Piper C, Wong-Baeza I, McHugh K, Ridley A, et al. HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I. J Immunol 2012;188: 6184-93.
23. Serwold T, Gaw S, Shastri N. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat Immunol 2001;2: 644-51.
24. Tian R, Wang S, Elisma F, Li L, Zhou H, Wang L, et al. Rare cell proteomic reactor applied to stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomics study of human embryonic stem cell differentiation. Mol Cell Proteomics 2011;10:M110.000679.
25. Cuomo A, Moretti S, Minucci S, Bonaldi T. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells. Amino Acids 2011;41: 387-99.
26. Guo HC, Madden DR, Silver ML, Jardetzky TS, Gorga JC, Strominger JL, et al. Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLAA* 0201, and HLA-B*2705. Proc Natl Acad Sci U S A 1993;90: 8053-7.
27. Madden DR, Gorga JC, Strominger JL, Wiley DC. The threedimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992;70: 1035-48.
28. Lopez de Castro JA, Alvarez I, Marcilla M, Paradela A, Ramos M, Sesma L, et al. HLA-B27: a registry of constitutive peptide ligands. Tissue Antigens 2004;63: 424-45.
29. Falk K, Rotzschke O, Grahovac B, Schendel D, Stevanovic S, Jung G, et al. Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics 1993;38: 161-2.
30. [published erratum appears in Immunogenetics 1994;39:379]
31. Buchsbaum S, Barnea E, Dassau L, Beer I, Milner E, Admon A. Large-scale analysis of HLA peptides presented by HLA-Cw4. Immunogenetics 2003;55: 172-6.
32. Falk K, Rotzschke O, Grahovac B, Schendel D, Stevanovic S, Gnau V, et al. Allele-specific peptide ligand motifs of HLA-C molecules. Proc Natl Acad Sci U S A 1993;90: 12005-9.
33. Ben Dror L, Barnea E, Beer I, Mann M, Admon A. The HLA-B*2705 peptidome. Arthritis Rheum 2010;62: 420-9.
34. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC. Identification of self peptides bound to purified HLA-B27. Nature 1991;353: 326-9.
35. Fiorillo MT, Meadows L, D'Amato M, Shabanowitz J, Hunt DF, Appella E, et al. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. Eur J Immunol 1997;27: 368-73.
36. Hearn A, York IA, Rock KL. The specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum. J Immunol 2009;183: 5526-36.
37. Goto Y, Hattori A, Ishii Y, Tsujimoto M. Reduced activity of the hypertension-associated Lys528Arg mutant of human adipocytederived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1. FEBS Lett 2006;580: 1833-8.
38. Kochan G, Krojer T, Harvey D, Fischer R, Chen L, Vollmar M, et al. Crystal structures of the endoplasmic reticulum aminopeptidase- 1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci U S A 2011;108: 7745-50.
39. Evnouchidou I, Kamal RP, Seregin SS, Goto Y, Tsujimoto M, Hattori A, et al. Coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme. J Immunol 2011;186: 1909-13.
40. Garcia-Medel N, Sanz-Bravo A, Van Nguyen D, Galocha B, Gomez-Molina P, Martin-Esteban A, et al. Functional interaction of the ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo. Mol Cell Proteomics 2012;11: 1416-29.
41. Bowness P, Allen RL, McMichael AJ. Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27. Eur J Immunol 1994;24: 2357-63.
42. Reeves E, Edwards CJ, Elliott T, James E. Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity. J Immunol 2013;191: 35-43.
43. Fung EY, Smyth DJ, Howson JM, Cooper JD, Walker NM, Stevens H, et al. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun 2009;10: 188-91.